Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37CA042324-19
Application #
6611767
Study Section
Special Emphasis Panel (NSS)
Program Officer
Stone, Helen B
Project Start
1985-09-01
Project End
2009-01-03
Budget Start
2004-04-01
Budget End
2005-01-31
Support Year
19
Fiscal Year
2004
Total Cost
$441,378
Indirect Cost
Name
Duke University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Pruszynski, Marek; Kang, Choong Mo; Koumarianou, Eftychia et al. (2018) d-Amino Acid Peptide Residualizing Agents for Protein Radioiodination: Effect of Aspartate for Glutamate Substitution. Molecules 23:
Zhou, Zhengyuan; Chitneni, Satish K; Devoogdt, Nick et al. (2018) Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation. Bioorg Med Chem 26:1939-1949
D'Huyvetter, Matthias; De Vos, Jens; Xavier, Catarina et al. (2017) 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment. Clin Cancer Res 23:6616-6628
Raghavan, Raghu; Howell, Roger W; Zalutsky, Michael R (2017) A model for optimizing delivery of targeted radionuclide therapies into resection cavity margins for the treatment of primary brain cancers. Biomed Phys Eng Express 3:
Zhou, Zhengyuan; Vaidyanathan, Ganesan; McDougald, Darryl et al. (2017) Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation. Mol Imaging Biol 19:867-877
Vaidyanathan, Ganesan; McDougald, Darryl; Choi, Jaeyeon et al. (2016) N-Succinimidyl 3-((4-(4-[(18)F]fluorobutyl)-1H-1,2,3-triazol-1-yl)methyl)-5-(guanidinomethyl)benzoate ([(18)F]SFBTMGMB): a residualizing label for (18)F-labeling of internalizing biomolecules. Org Biomol Chem 14:1261-71
Vaidyanathan, Ganesan; McDougald, Darryl; Choi, Jaeyeon et al. (2016) Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET. J Nucl Med 57:967-73
Vaidyanathan, Ganesan; McDougald, Darryl; Koumarianou, Eftychia et al. (2015) Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG. Nucl Med Biol 42:673-84
Pruszy?ski, Marek; ?yczko, Monika; Bilewicz, Aleksander et al. (2015) Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals. Nucl Med Biol 42:439-445
Pruszynski, Marek; Koumarianou, Eftychia; Vaidyanathan, Ganesan et al. (2015) D-Amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodination. Nucl Med Biol 42:19-27

Showing the most recent 10 out of 156 publications